Skip to content

13F-HR filed by Crestline Management, L.P.

Crestline Management, L.P. filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 3 holding rows worth $53,326,374.

Accession
0001315863-26-000165
Filed
2026-02-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2025

A holdings report, 3 entries on the cover page, a total value of $53,326,374 stated on the cover page (in dollars after the unit check, H1), rows summing to $53,326,374 with VALUE read as dollars as filed, 13F file number 028-14917. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DENALI THERAPEUTICS INC COM24823R105Stock2,810,732$46,405,185dollars as filed
SANA BIOTECHNOLOGY INC799566104COM1,220,937$4,969,214dollars as filed
8X8 INC282914100COMMON STOCK990,580$1,951,975dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001315863-26-000165this filing2026-02-17acceptance time not in the bulk data set